EGFR and neoplasm: A time-dependent increase in BRET signal (DY605-CTX/NLuc-EGFR binding) was observed, suggesting that most of the DY605-CTX was still in the vascular space immediately post administration with increasing tumor penetration and target engagement over time (Figures 6A–6C and 6E).